Morgan Stanley on Rubius (RUBY) New Strategy and Restructuring: 'removes potential for near-term clinical catalyst'

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. DVLT
8. ADYYF
9. WDAY
10. ADYEN:NA

Go back to Morgan Stanley on Rubius (RUBY) New Strategy and Restructuring: 'removes potential for near-term clinical catalyst'

Form 8-K Rubius Therapeutics, For: Sep 13

September 13, 2022 7:16 AM EDT

0001709401 false 0001709401 2022-09-13 2022-09-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares... More